| Literature DB >> 26385523 |
Sarah Legrain1, Dan Su1, Cor Breukel2, Laurent Detalle1, Jill W Claassens2, Jos van der Kaa2, Shozo Izui3, J Sjef Verbeek2, Jean-Paul Coutelier4.
Abstract
IgM anti-mouse platelet autoantibodies cause thrombocytopenia by mediating uptake of opsonized thrombocytes, whereas IgM anti-erythrocyte autoantibodies induce anemia through a phagocytosis-independent cell destruction. In this article, we show that infection with lactate dehydrogenase-elevating virus, a benign mouse arterivirus, exacerbates the pathogenicity of IgM anti-platelet, but not anti-erythrocyte autoantibodies. To define the role of Fcα/μ receptor (Fcα/μR) in IgM-mediated thrombocytopenia and anemia, we generated mice deficient for this receptor. These animals were resistant to IgM autoantibody-mediated thrombocytopenia, but not anemia. However, the lactate dehydrogenase-elevating virus-induced exacerbation of thrombocytopenia was not associated with enhanced Fcα/μR expression on macrophages. These results indicate that Fcα/μR is required for the pathogenicity of IgM anti-platelet autoantibodies but is not sufficient to explain the full extent of the disease in virally infected animals.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26385523 DOI: 10.4049/jimmunol.1500798
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422